Hannah Mamuszka is the current director at Bionano Genomics. Hannah has also previously served as the chief at Carolina Health Informatics Program, as well as the VP of Business Development at Exosome Diagnostics.
Mamuszka has been in the health informatics field for over 10 years. Hannah started their career at Asuragen, where they reformatted the company's approach to pharma clients. Hannah then moved to Exosome Diagnostics, where they completed several milestone transactions which allowed the company to go from a startup to a commercial stage company.
Hannah Mamuszka attended Harvard University for their undergraduate degree and then went on to get their masters degree from the University of Maryland.